(Q37813410)

23 August 2017

1 reference

title

Infection and chronic allograft dysfunction (English)

1 reference

23 August 2017

2

0 references

Matthias Cavassini

0 references

author name string

Peter J Dupont

series ordinal

1

1 reference

23 August 2017

Manuel Pascual

series ordinal

3

1 reference

23 August 2017

publication date

1 December 2010

1 reference

Kidney International. Supplement

23 August 2017

published in

1 reference

23 August 2017

issue

119

1 reference

23 August 2017

page(s)

S47-53

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2010.423

23 August 2017

exact match

0 references

cites work

Improved graft survival after renal transplantation in the United States, 1988 to 1996

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Immunosuppressive strategies in transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Strategies to improve long-term outcomes after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

New human papovavirus (B.K.) isolated from urine after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

BK polyoma virus nephropathy in kidney transplant recipient: the role of new immunosuppressive agents

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

BK polyoma virus nephropathy among Iranian renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

BK virus nephropathy in renal transplant patients in London.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Prospective monitoring of BK virus replication in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Polyomavirus nephropathy after renal transplantation: a single centre experience

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

BK virus nephritis after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

BK virus nephropathy and kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Polyomavirus nephropathy in pediatric kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Prospective monitoring of BK polyomavirus infection early posttransplantation in nonrenal solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Negative impact of human leukocyte antigen matching in the outcome of polyomavirus nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Urine cytology as a useful screening method for polyoma virus nephropathy in renal transplant patients: a single-center experience.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Case studies in cost effectiveness of molecular diagnostics for infectious diseases: pulmonary tuberculosis, enteroviral meningitis, and BK virus nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Prospective study of infection and nephropathy due to BK and JC polyomavirus in 76 kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

BK transplant nephropathy successfully treated with cidofovir

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Use of leflunomide in the treatment of polyomavirus BK-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Histologic versus molecular diagnosis of BK polyomavirus-associated nephropathy: a shifting paradigm?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Monitoring of polyomavirus BK virus viruria and viremia in renal allograft recipients by use of a quantitative real-time PCR assay: one-year prospective study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

The clinical significance of cytomegaloviral inclusions in the allograft kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

De novo immunotactoid glomerulopathy of the renal allograft: possible association with cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Comparison of the immediate early polypeptides of human cytomegalovirus isolates

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

p53 expression in CMV-infected cells: association with the alternative expression of the p53 transactivated genes p21/WAF1 and MDM2

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Persistent cytomegalovirus infection is associated with increased expression of TGF-beta1, PDGF-AA and ICAM-1 and arterial intimal thickening in kidney allografts

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Cytomegalovirus infection enhances connective tissue growth factor mRNA expression in a rat model of chronic renal allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Expression of TGF-beta and PDGF-AA antigens and corresponding mRNAs in cytomegalovirus-infected rat kidney allografts

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Increased urinary excretion of transforming growth factor-beta(1) in renal transplant recipients during cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Cytomegalovirus stimulated mRNA accumulation and cell surface expression of the oxidized LDL scavenger receptor, CD36.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Late-onset cytomegalovirus disease in patients with solid organ transplant

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

What is the impact of late-onset cytomegalovirus disease after valganciclovir prophylaxis in kidney transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Late urinary-tract infection after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Bacterial urinary tract infection in cyclosporine-A immunosuppressed renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Urinary tract infection in renal transplant patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Hospitalizations for bacterial septicemia after renal transplantation in the united states

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Major infectious complications after kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Urinary tract infection in the immunocompromised host. Lessons from kidney transplantation and the AIDS epidemic

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Infectious disease complications of renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Acute pyelonephritis represents a risk factor impairing long-term kidney graft function.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Acute graft pyelonephritis and long-term kidney allograft outcome.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

New renal scars in children with severe VUR: a 10-year study of randomized treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Post-transplantation pyelonephritis: factors producing low patient and transplant morbidity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Urinary tract infections after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Late urinary tract infection after transplantation: prevalence, predisposition and morbidity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Late urinary tract infection after renal transplantation in the United States

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Effects of urinary tract infection on outcomes after renal transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Late recurrent urinary tract infections may produce renal allograft scarring even in the absence of symptoms or vesicoureteric reflux

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Management of urinary tract infections and lymphocele in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Identifying the patient at risk for post-transplant lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Postransplant lymphoproliferative disorder localized near the allograft in renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Renal disease associated with hepatitis C infection after kidney and liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Hepatitis C virus-related kidney disease: an overview.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Focal segmental glomerulosclerosis in a 32-year-old kidney allograft after 7 years without immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Hemorrhagic adenovirus cystitis after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Acute adenoviral infection of a graft by serotype 35 following renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Adenovirus-associated hemorrhagic cystitis in a pediatric renal transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Parvovirus B19 infection after transplantation: a review of 98 cases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Human parvovirus B19 infection in organ transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.423

7 January 2021

Identifiers

DOI

10.1038/KI.2010.423

1 reference

Dimensions Publication ID

23 August 2017

1023503658

0 references

1 reference